Anthelmintic Drugs Market Report 2024 (Global Edition)

Global Anthelmintic Drugs Market Report 2024 Market Size Split by Drug Class (Benzimidazoles, Piperazine, Others), by Application (Human, Animal), by Route of Administration (Oral, Injectable), by Dis...

Anthelmintic Drugs Market Report Description

We have various report editions of Anthelmintic Drugs Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Anthelmintic Drugs Market

The major players adopt inventive strategies quickly to gain an edge over their rivals and take a major market share. To serve a sizable customer base and obtain a competitive advantage, major players in the Anthelmintic Drugs market place an enormous value on extending their unique offers.

Anthelmintic Drugs Industry News

• February 2021, Merck said that the FDA had approved KOMBITRIM, their newest oral combination medication, to treat certain worm-caused parasitic diseases in both adults and children. Ivermectin and albendazole, two popular anthelmintic drugs, are combined in a pill called KOMBITRIM.

(Source: www.merck.com/news/merck-statement-on-ivermectin-use-during-the-covid-19-pandemic/)

Top Companies Market Share in Anthelmintic Drugs Industry: (In no particular order of Rank)

• GlaxoSmithKline plc 
• Johnson & Johnson 
• Merck & Co. Inc. 
• Bayer AG 
• Cipla Ltd. 
• Sun Pharmaceutical Industries Ltd. 
• Teva Pharmaceutical Industries Limited 
• Reese Pharmaceutical Company 
• Zydus Lifesciences Limited
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

In terms of revenue, the North American Anthelmintic Drugs Market share was 40% of the total market

According to Cognitive Market Research, North America led the market in 2023 and generated around 40% of worldwide revenue; the region's focus on preventive measures, growing knowledge of parasitic illnesses, and sophisticated healthcare infrastructure all support market growth. North America efficiently addresses helminthic illnesses and is a key player in defining the trajectory of the anthelmintic drug market due to its thriving veterinary industry and proactive human healthcare practices.

Europe is the fastest-growing category as Market expansion is fuelled by the region's modern veterinary practices, preventative medicine focus, and strict healthcare standards. Europe has a significant influence on the direction of the anthelmintic drug market, helping to address its population's various healthcare demands while raising awareness of helminthic infections and demonstrating a strong commitment to sustainable agriculture.

The current report Scope analyzes Anthelmintic Drugs Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Anthelmintic Drugs Market

According to Cognitive Market Research, the global Anthelmintic Drugs market size was estimated at USD 1121.5 Million out of which North America held the major market of more than 40% of the global revenue with a market size of USD 448.60 million in 2023 and will grow at a compound annual growth rate (CAGR) of 2.5% from 2023 to 2030.The market for anthelmintic drugs is expanding rapidly in North America due to factors such as a developed healthcare system, rising public awareness of parasitic illnesses, and a focus on preventative healthcare. The veterinary industry's need for anthelmintic medications to treat parasitic worm diseases in animals is a significant factor driving this rise. All things considered, North America's proactive approach to the treatment of people and animals places the continent in a position to significantly shape the market for anthelmintic drugs by highlighting the significance of preventative measures in the fight against helminthic infections and upholding public health standards.

• According to Cognitive Market Research, the US had a major share in the Anthelmintic Drugs market with a market size of USD 353.95 million in 2023 and is projected to grow at a CAGR of 2.3% during the forecast period. This is majorly due to its strict regulations. 
• The Canada Anthelmintic Drugs market had a market share of USD 53.83 million in 2023 and is projected to grow at a CAGR of 3.3% during the forecast period. This is due to the focus on preventive healthcare. 
• The Mexico Anthelmintic Drugs market is projected to witness growth at a CAGR of 3.0% during the forecast period with a market size of USD 40.82 million in 2023.

Europe Anthelmintic Drugs Market

According to Cognitive Market Research, with a market value of USD 1121.5 million in 2023 and projected to expand at a compound annual growth rate (CAGR) of 2.8% from 2023 to 2030, Europe accounted for a share of over 30% of the global Anthelmintic Drugs market size of USD 336.45 million. The market for anthelmintic drugs is expanding significantly in Europe because of the region's improved veterinary practices, high awareness of parasite illnesses, and strict healthcare regulations. The need for anthelmintic medications in cattle is a significant factor driving this growth and is consistent with Europe's commitment to sustainable agriculture. Because of its focus on ethical and preventative medicine, the region is well-positioned to shape the market for anthelmintic drugs, catering to the various demands of both veterinary and human populations. Europe's dedication to sustainability and health emphasizes how important a role it plays in promoting the market for anthelmintic drugs ongoing expansion.

• According to Cognitive Market Research, the Germany Anthelmintic Drugs market size was valued at USD 66.62 million in 2023 and is projected to grow at a CAGR of 3.0% during the forecast period. This is majorly due to the growth of the veterinary industry. 
• The United Kingdom Anthelmintic Drugs market had a market share of USD 56.52 million in 2023 and is projected to grow at a CAGR of 3.6% during the forecast period. This is due to the increased knowledge of helminthic illnesses. 
• The France Anthelmintic Drugs market is projected to witness growth at a CAGR of 2.0% during the forecast period with a market size of USD 30.95 million in 2023.
• The Italy Anthelmintic Drugs market is projected to witness growth at a CAGR of 2.2% during the forecast period with a market size of USD 28.93 million in 2023.
• The Russia Anthelmintic Drugs market is projected to witness growth at a CAGR of 1.8% during the forecast period with a market size of USD 52.15 million in 2023.
• The Spain Anthelmintic Drugs market is projected to witness growth at a CAGR of 1.9% during the forecast period with a market size of USD 27.59 million in 2023.
• The Portugal Anthelmintic Drugs market is projected to witness growth at a CAGR of 2.6% during the forecast period with a market size of USD 7.07 million in 2023.
• The Luxembourg Anthelmintic Drugs market is projected to witness growth at a CAGR of 2.9% during the forecast period with a market size of USD 10.43 million in 2023.
• The Greece Anthelmintic Drugs market is projected to witness growth at a CAGR of 3.1% during the forecast period with a market size of USD 4.04 million in 2023.
• The Rest of Europe Anthelmintic Drugs market is projected to witness growth at a CAGR of 1.5% during the forecast period with a market size of USD 52.15 million in 2023.

Asia Pacific Anthelmintic Drugs Market

According to Cognitive Market Research, the global Anthelmintic Drugs market size was estimated at USD 1121.5 Million out of which Asia Pacific held the market of more than 23% of the global revenue with a market size of USD 257.95 million in 2023 and will grow at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2030. The market for anthelmintic drugs is expanding significantly in the Asia Pacific area due to increased attention on livestock health, greater veterinary care, and growing awareness of parasitic illnesses. The use of anthelmintic medications in agriculture, notably in treating helminthic diseases in a variety of animal populations, is a significant factor in this expansion. Asia Pacific is positioned to play a crucial role in defining the anthelmintic drug market, satisfying the changing healthcare needs of its diversified and expanded population. This is due to the region's dynamic healthcare landscape and focus to improving animal welfare. In general, the market's expansion is greatly aided by the Asia Pacific area, which emphasizes preventive measures and advances veterinary procedures.

• According to Cognitive Market Research, the China Anthelmintic Drugs market size was valued at USD 116.08 million in 2023 and is projected to grow at a CAGR of 5.8% during the forecast period. This is majorly due to the increased emphasis on enhancing livestock health. 
• The India Anthelmintic Drugs market had a market share of USD 30.95 million in 2023 and is projected to grow at a CAGR of 8.1% during the forecast period. This is due to the rising demand for premium animal products. 
• The Japan Anthelmintic Drugs market is projected to witness growth at a CAGR of 4.8% during the forecast period with a market size of USD 35.60 million in 2023.
• The South Korea Anthelmintic Drugs market is projected to witness growth at a CAGR of 5.4% during the forecast period with a market size of USD 25.79 million in 2023.
• The Australia Anthelmintic Drugs market is projected to witness growth at a CAGR of 6.0% during the forecast period with a market size of USD 13.41 million in 2023.
• The South East Asia Anthelmintic Drugs market is projected to witness growth at a CAGR of 7.3% during the forecast period with a market size of USD 17.80 million in 2023.
• The Rest of Asia Pacific Anthelmintic Drugs market is projected to witness growth at a CAGR of 6.1% during the forecast period with a market size of USD 18.31 million in 2023.

South America Anthelmintic Drugs Market

According to Cognitive Market Research, the global Anthelmintic Drugs market size was estimated at USD 1121.5 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 56.08 million in 2023 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2023 to 2030. The market for anthelmintic drugs is expanding significantly in Latin America due to the region's vast agricultural landscapes and emphasis on livestock health. The use of anthelmintic medications to treat parasitic worm illnesses in a variety of animal populations is a noteworthy component of this expansion, supporting the area's dedication to sustainable agriculture. Latin America is a major force in the development of the anthelmintic drug industry, despite obstacles associated with restricted access to healthcare facilities. The region emphasizes the value of preventative measures in the fight against helminthic illnesses and in promoting animal welfare in general. Due to its dynamic agricultural methods and increasing public awareness of parasitic illnesses, the region is well-positioned to support the market's sustained expansion and development for anthelmintic drugs.

• According to Cognitive Market Research, the Brazil Anthelmintic Drugs market size was valued at USD 24.00 million in 2023 and is projected to grow at a CAGR of 4.3% during the forecast period. This is majorly due to the increased public awareness of parasitic illnesses. 
• The Argentina Anthelmintic Drugs market had a market share of USD 9.42 million in 2023 and is projected to grow at a CAGR of 4.6% during the forecast period. This is due to the growing emphasis on preventative healthcare measures. 
• The Colombia Anthelmintic Drugs market is projected to witness growth at a CAGR of 3.5% during the forecast period with a market size of USD 4.99 million in 2023.
• The Peru Anthelmintic Drugs market is projected to witness growth at a CAGR of 3.9% during the forecast period with a market size of USD 4.60 million in 2023.
• The Chile Anthelmintic Drugs market is projected to witness growth at a CAGR of 4.0% during the forecast period with a market size of USD 4.04 million in 2023.
• The Rest of Latin America Anthelmintic Drugs market is projected to witness growth at a CAGR of 2.8% during the forecast period with a market size of USD 9.03 million in 2023.

Middle East and Africa Anthelmintic Drugs Market

According to Cognitive Market Research, the global Anthelmintic Drugs market size was estimated at USD 1121.5 Million out of which Middle East and Africa held the major market of more than 2% of the global revenue with a market size of USD 22.43 million in 2023 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2023 to 2030. Due to a growing emphasis on treating the common parasite illnesses in the Middle East and Africa, the market for anthelmintic drugs is expanding in these regions. The use of anthelmintic medications in animal husbandry is a noteworthy sector driving this rise, in line with the region's focus on sustainable agriculture. Notwithstanding obstacles, the Middle East and Africa region is significantly influencing the market for anthelmintic drugs, highlighting the significance of preventative measures in the fight against helminthic illnesses and the promotion of general animal health in a variety of habitats.

• According to Cognitive Market Research, the GCC Countries Anthelmintic Drugs market size was valued at USD 9.60 million in 2023 and is projected to grow at a CAGR of 4.8% during the forecast period. This is majorly due to the developed veterinary industry. 
• The South Africa Anthelmintic Drugs market had a market share of USD 3.54 million in 2023 and is projected to grow at a CAGR of 5.0% during the forecast period. This is due to the sophisticated healthcare infrastructure. 
• The Egypt Anthelmintic Drugs market is projected to witness growth at a CAGR of 2.6% during the forecast period with a market size of USD 2.36 million in 2023.
• The Turkey Anthelmintic Drugs market is projected to witness growth at a CAGR of 3.5% during the forecast period with a market size of USD 1.93 million in 2023.
• The Nigeria Anthelmintic Drugs market is projected to witness growth at a CAGR of 3.1% during the forecast period with a market size of USD 2.36 million in 2023.
• The Rest of MEA Anthelmintic Drugs market is projected to witness growth at a CAGR of 3.0% during the forecast period with a market size of USD 2.65 million in 2023.

Anthelmintic Drugs Market Analysis

Anthelmintic Drugs Drug Class Segment Analysis

According to Cognitive Market Research, benzimidazoles held the major market share over the forecast period. Benzimidazoles are a popular alternative for treating helminthic diseases since they interfere with the helminths' metabolism and are utilized in both veterinary and human medicine. The increasing popularity of benzimidazoles in the growing anthelmintic drug market is largely due to their adaptability and efficiency.

Piperazine is the fastest-growing category over the forecast period. Piperazine, well-known for its effectiveness against various parasitic worms, paralyzes the worms' neuromuscular system. Because of its broad-spectrum activity and efficacy, Piperazine is a major participant in treating helminthic infections in various populations. It is used extensively in both veterinary and human medicine.

• Benzimidazoles
• Piperazine
• Others

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Anthelmintic Drugs Industry. Request a Free Sample PDF!

Anthelmintic Drugs End-User Segment Analysis

According to Cognitive Market Research, humans hold a prominent market share. The need for anthelmintic medications in human healthcare has been fueled by growing awareness of helminthic infections and the value of prophylactic interventions. This increase underscores the market's importance in addressing global health concerns connected to helminthic infections and demonstrates a proactive strategy for eradicating parasitic worms in the human population.

Animals are the fastest-growing category over the forecast period. Anthelmintic medications are essential for treating and preventing parasitic worm infections in animals, emphasizing enhancing livestock health and productivity. The market's growth in the animal industry highlights how crucial anthelmintics are to maintaining livestock welfare and guaranteeing the best standards in agriculture.

• Human
• Animal

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Anthelmintic Drugs Route of Administration Segment Analysis

According to Cognitive Market Research, oral holds a prominent market share. Both humans and animals can benefit from the easy and efficient delivery methods that oral anthelmintic medications offer. The market for anthelmintic drugs has grown overall as a result of the emphasis on oral delivery, which meets the demand for treatment choices that are easy to use and convenient to get.

Injectables are the fastest-growing category over the forecast period. In human and veterinary medicine, injectable anthelmintic medications provide focused and effective therapy options for parasitic worm infections. The market's ability to adapt to a range of administration choices and the demand for accurate and efficient delivery systems in treating helminthic illnesses are highlighted by the rise in injectable solutions.

• Oral
• Injectable

Anthelmintic Drugs Distribution Channel Segment Analysis

According to Cognitive Market Research, hospital pharmacies hold a prominent market share. These stores are essential for providing anthelmintic medications for veterinary and human usage, which helps the market grow. Hospital pharmacies play a crucial role in the delivery of anthelmintics, providing access to these necessary drugs and aiding medical programs that treat parasitic worm illnesses.

Retail pharmacies are the fastest-growing category over the forecast period. These stores act as easily accessible locations where people can get anthelmintic drugs for human and veterinary usage. The ease of use and accessibility offered by retail pharmacies are crucial in satisfying the need for anthelmintic medications, fostering the industry's growth, and aiding in the fight against parasitic worm illnesses.

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Veterinary Pharmacies
• Veterinary Hospitals & Clinics

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion